BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 10691289)

  • 1. Par-4: an emerging pivotal player in neuronal apoptosis and neurodegenerative disorders.
    Mattson MP; Duan W; Chan SL; Camandola S
    J Mol Neurosci; 1999; 13(1-2):17-30. PubMed ID: 10691289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis by Par-4 in cancer and neurodegenerative diseases.
    El-Guendy N; Rangnekar VM
    Exp Cell Res; 2003 Feb; 283(1):51-66. PubMed ID: 12565819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate apoptosis response-4 production in synaptic compartments following apoptotic and excitotoxic insults: evidence for a pivotal role in mitochondrial dysfunction and neuronal degeneration.
    Duan W; Rangnekar VM; Mattson MP
    J Neurochem; 1999 Jun; 72(6):2312-22. PubMed ID: 10349840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation of prostate apoptosis response-4 in degeneration of dopaminergic neurons in models of Parkinson's disease.
    Duan W; Zhang Z; Gash DM; Mattson MP
    Ann Neurol; 1999 Oct; 46(4):587-97. PubMed ID: 10514095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate apoptosis response-4 mediates trophic factor withdrawal-induced apoptosis of hippocampal neurons: actions prior to mitochondrial dysfunction and caspase activation.
    Chan SL; Tammariello SP; Estus S; Mattson MP
    J Neurochem; 1999 Aug; 73(2):502-12. PubMed ID: 10428045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptotic and antiapoptotic mechanisms in stroke.
    Mattson MP; Culmsee C; Yu ZF
    Cell Tissue Res; 2000 Jul; 301(1):173-87. PubMed ID: 10928290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-apoptotic action of PAR-4 involves inhibition of NF-kappaB activity and suppression of BCL-2 expression.
    Camandola S; Mattson MP
    J Neurosci Res; 2000 Jul; 61(2):134-9. PubMed ID: 10878585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Par-4 is a synaptic protein that regulates neurite outgrowth by altering calcium homeostasis and transcription factor AP-1 activation.
    Guo Q; Xie J; Chang X; Zhang X; Du H
    Brain Res; 2001 Jun; 903(1-2):13-25. PubMed ID: 11382383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation of par-4 in the degeneration of striatal neurons induced by metabolic compromise with 3-nitropropionic acid.
    Duan W; Guo Z; Mattson MP
    Exp Neurol; 2000 Sep; 165(1):1-11. PubMed ID: 10964480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate apoptosis response-4 enhances secretion of amyloid beta peptide 1-42 in human neuroblastoma IMR-32 cells by a caspase-dependent pathway.
    Guo Q; Xie J; Chang X; Du H
    J Biol Chem; 2001 May; 276(19):16040-4. PubMed ID: 11278808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the involvement of Par-4 in ischemic neuron cell death.
    Culmsee C; Zhu Y; Krieglstein J; Mattson MP
    J Cereb Blood Flow Metab; 2001 Apr; 21(4):334-43. PubMed ID: 11323519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly (ADP-ribose) (PAR)-dependent cell death in neurodegenerative diseases.
    Park H; Kam TI; Dawson TM; Dawson VL
    Int Rev Cell Mol Biol; 2020; 353():1-29. PubMed ID: 32381174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease.
    Guo Q; Fu W; Xie J; Luo H; Sells SF; Geddes JW; Bondada V; Rangnekar VM; Mattson MP
    Nat Med; 1998 Aug; 4(8):957-62. PubMed ID: 9701251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodegenerative disorders and ischemic brain diseases.
    Mattson MP; Duan W; Pedersen WA; Culmsee C
    Apoptosis; 2001; 6(1-2):69-81. PubMed ID: 11321043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that Par-4 participates in the pathogenesis of HIV encephalitis.
    Kruman II; Nath A; Maragos WF; Chan SL; Jones M; Rangnekar VM; Jakel RJ; Mattson MP
    Am J Pathol; 1999 Jul; 155(1):39-46. PubMed ID: 10393834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy and apoptosis dysfunction in neurodegenerative disorders.
    Ghavami S; Shojaei S; Yeganeh B; Ande SR; Jangamreddy JR; Mehrpour M; Christoffersson J; Chaabane W; Moghadam AR; Kashani HH; Hashemi M; Owji AA; Łos MJ
    Prog Neurobiol; 2014 Jan; 112():24-49. PubMed ID: 24211851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNAi knockdown of Par-4 inhibits neurosynaptic degeneration in ALS-linked mice.
    Xie J; Awad KS; Guo Q
    J Neurochem; 2005 Jan; 92(1):59-71. PubMed ID: 15606896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Par-4 sensitizes TRAIL-induced apoptosis via inactivation of NF-kappaB and Akt signaling pathways in renal cancer cells.
    Lee TJ; Jang JH; Noh HJ; Park EJ; Choi KS; Kwon TK
    J Cell Biochem; 2010 Apr; 109(5):885-95. PubMed ID: 20127709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling.
    Wu Y; Chen M; Jiang J
    Mitochondrion; 2019 Nov; 49():35-45. PubMed ID: 31288090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
    Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
    Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.